Learn more at LeadIQ.com

Insights

Regenerative Medicine Focus Surrozen specializes in regenerative medicines targeting the Wnt signaling pathway, offering potential collaboration opportunities with companies interested in innovative therapeutic approaches.

Scientific Expertise The company was founded by established scientists with extensive experience in Wnt signaling, providing a strong foundation for partnerships with businesses seeking cutting-edge research capabilities.

Funding and Growth With recent funding of $18M and revenue potential in the $0-10M range, Surrozen presents an opportunity for investment or strategic partnerships with companies looking to support the growth of promising biotechnology ventures.

Employee Recruitment Surrozen is actively seeking creative scientists to join their team, indicating potential recruitment partnerships with recruitment agencies or services catering to the biotechnology sector.

Market Positioning Among similar companies, Surrozen stands out with its unique focus and expertise, making it an attractive target for collaborations, acquisitions, or joint ventures in the biotechnology research space.

Similar companies to Surrozen

Surrozen Tech Stack

Surrozen uses 8 technology products and services including jQuery CDN, Handlebars, Open Graph, and more. Explore Surrozen's tech stack below.

jQuery CDN
Content Delivery Network
Handlebars
Javascript Frameworks
Open Graph
Miscellaneous
Module Federation
Miscellaneous
Microsoft
Miscellaneous
Webflow
Page Builders
Akamai Bot Manager
Security
Nginx
Web Servers

Media & News

Surrozen's Email Address Formats

Surrozen uses at least 1 format(s):

Surrozen Email Formats	Example	Percentage
First@surrozen.com	John@surrozen.com	80%
FLast@surrozen.com	JDoe@surrozen.com	13%
Last@surrozen.com	Doe@surrozen.com	4%
First-L@surrozen.com	John-D@surrozen.com	3%

Frequently Asked Questions

Where is Surrozen's headquarters located?

Surrozen's main headquarters is located at 171 Oyster Point Blvd South San Francisco, California 94080 US. The company has employees across 2 continents, including North AmericaEurope.

What is Surrozen's stock symbol?

Surrozen is a publicly traded company; the company's stock symbol is SRZN.

What is Surrozen's official website and social media links?

Surrozen's official website is surrozen.com and has social profiles on LinkedIn.

How much revenue does Surrozen generate?

As of August 2024, Surrozen's annual revenue reached $7.5M.

What is Surrozen's SIC code NAICS code?

Surrozen's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Surrozen have currently?

As of August 2024, Surrozen has approximately 67 employees across 2 continents, including North AmericaEurope. Key team members include Chief Scientific Officer: W. Y.Chief Operating Officer: C. W.Head Of Quality: T. C.. Explore Surrozen's employee directory with LeadIQ.

What industry does Surrozen belong to?

Surrozen operates in the Biotechnology Research industry.

What technology does Surrozen use?

Surrozen's tech stack includes jQuery CDNHandlebarsOpen GraphModule FederationMicrosoftWebflowAkamai Bot ManagerNginx.

What is Surrozen's email format?

Surrozen's email format typically follows the pattern of . Find more Surrozen email formats with LeadIQ.

How much funding has Surrozen raised to date?

As of August 2024, Surrozen has raised $18M in funding. The last funding round occurred on Apr 01, 2024 for $18M.

Surrozen

Surrozen

Biotechnology ResearchCalifornia, United States51-200 Employees

Surrozen is a biotechnology company focused on discovering and developing novel regenerative medicines with a focus on unlocking the powerful self-renewal properties of the body through specific control of the Wnt signaling pathway.

Surrozen was founded by five leading-edge scientists: K. Christopher Garcia, Ph.D., Roel Nusse, Ph.D. and Calvin Kuo, M.D., Ph.D. from Stanford University; Claudia Janda, Ph.D. from the Princess Maxima Center for Pediatric Oncology; and Hans Clevers, M.D, Ph.D. from the Hubrecht Institute and Princess Maxima Center. Each has conducted extensive research on Wnt signaling, with findings that together shape Surrozen’s technology and approach to therapeutic development. The company is backed by The Column Group, a leading biotechnology venture capital firm.

We are currently seeking highly creative scientists to join our team, and invite you to explore career opportunities on our website.

Company Overview

Headquarters: 171 Oyster Point Blvd South San Francisco, California 94080 US
Website: surrozen.com
SIC Code: 8733 - Noncommercial Research Organizations
Stock Symbol: SRZN
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees: 51-200

Media & News

Funding & Financials

$18M
Surrozen has raised a total of $18M of funding over 5 rounds. Their latest funding round was raised on Apr 01, 2024 in the amount of $18M.
$10M
Surrozen's revenue is in the range of $10M

Funding & Financials

$18M
Surrozen has raised a total of $18M of funding over 5 rounds. Their latest funding round was raised on Apr 01, 2024 in the amount of $18M.
$10M
Surrozen's revenue is in the range of $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.